Needham & Company Reiterates a 'Buy' on Dyax (DYAX); Company Remains Focused on Building Steadily Growing Patient Base
Tweet Send to a Friend
Needham & Company reiterates a 'Buy' rating on Dyax Corp. (Nasdaq: DYAX), price target $8.
Needham analyst says, "Yesterday, we ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst says, "Yesterday, we ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
